Tsepamo Plus: Expanded Congenital Abnormalities Surveillance with an Emulated Clinical Trial to Evaluate Weight Impact on Birth Outcomes for Newer ART Regimens
Tsepamo Plus: Expanded Congenital Abnormalities Surveillance with an Emulated Clinical Trial to Evaluate Weight Impact on Birth Outcomes for Newer ART Regimens
批准号:
10381145
负责人:
Roger L Shapiro
金额:
$22.35万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-24 至 2026-08-31
中文摘要
项目摘要/摘要,TSepamo Plus(项目1)
抗逆转录病毒治疗(ART)指南取决于妊娠期的安全性和有效性数据,特别是在
资源有限的情况下,方案依赖单一的ART方案作为所有孕妇的一线治疗
以及未怀孕的成年人。目前考虑在怀孕期间使用现代ART养生法--尤其是
那些含有多洛替格列韦(DTG)和替诺福韦丙氨酰胺(TAF)的药物-包括了解对神经的风险
输卵管缺陷(NTDS)和体重增加对妊娠结局的影响。特塞帕莫研究
(R01HD080471,R01HD095766)是非洲最大的妊娠监测系统,已评估超过
自2014年以来,博茨瓦纳共交付了18万份快递。这项研究提供了关键的安全数据和治疗指导
与博茨瓦纳抗逆转录病毒治疗方案中早期采用的具体抗逆转录病毒疗法有关。在……里面
2018年,TSepamo的研究表明了与DTG和NTDS的潜在关联,虽然这一担忧已经
虽然在扩大监测后随着时间的推移有所下降,但它并没有消失。正在进行的NTD监视是
DTG和其他新的抗逆转录病毒药物都需要。关于体重增加的新考虑
现代抗逆转录病毒疗法在特塞帕莫也得到了成功的分析,但进一步的数据按基线分层
母体体重组是必要的。现有的特塞帕莫奖的资金用于继续进行出生监测
到2022年12月,P01机制可以从1月起再延长4年
2023年至2026年12月。这将使目标得以完成,这些目标包括:1)持续监测
了解和描述较长时期内与DTG相关的神经管缺陷风险,以及
对膳食叶酸摄入量的额外评估;2)进行一项模拟临床试验的新目标,比较
在不同重量层使用时最相关的ART养生法;以及3)利用唯一识别符的新目标
在我们的监测中第一次捕获多个怀孕的数据。这些新奇的目标
利用博茨瓦纳独特的艺术景观,并以我们高度重视的科学发现为基础
生产性监视系统。这项研究产生的数据将对更新国际
妊娠期抗逆转录病毒药物的使用指南。
英文摘要
Project Summary/Abstract, Tsepamo Plus (Project 1)
Antiretroviral treatment (ART) guidelines depend upon safety and efficacy data in pregnancy, especially in
resource-limited settings where programs rely on a single ART regimen as first-line treatment for all pregnant
and non-pregnant adults. Current considerations for using modern ART regimens in pregnancy – especially
those containing dolutegravir (DTG) and tenofovir alafenamide (TAF) – include understanding the risks for neural
tube defects (NTDs) and for the effect of weight gain on pregnancy outcomes. The Tsepamo Study
(R01HD080471, R01HD095766) is the largest pregnancy surveillance system in Africa, and has evaluated over
180,000 deliveries in Botswana since 2014. The study has provided critical safety data and treatment guidance
related to specific ART regimens that have been adopted for early use within the Botswana ART program. In
2018, the Tsepamo Study demonstrated a potential association with DTG and NTDs, and while this concern has
decreased over time following expanded surveillance, it has not disappeared. Ongoing NTD surveillance is
required both for DTG and for other new antiretroviral agents. New considerations regarding weight gain with
modern ART regimens have also been analyzed successfully in Tsepamo, but further data stratified by baseline
maternal weight groups are needed. The existing Tsepamo award was funded to continue birth surveillance
through December 2022, and the P01 mechanism can extend surveillance for 4 additional years from January
2023 through December 2026. This will allow the completion of aims that include: 1) ongoing surveillance to
understand and characterize the neural tube defect risk associated with DTG over a longer period, and with
additional evaluation of dietary folic acid intake; 2) a new aim to conduct an emulated clinical trial comparing the
most relevant ART regimens when used at different weight strata; and 3) new aims that utilize a unique identifier
to capture data across multiple pregnancies for the first time in our surveillance. These novel aims take
advantage of the unique ART landscape in Botswana, and build on the scientific findings from our highly
productive surveillance system. Data generated from this study will be critical for updating international
guidelines for the use of ART in pregnancy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Closing Research Gaps in Antiretroviral Treatment for Pregnant Women and Infants Living with HIV
-
批准号:10495240
-
项目类别:
-
资助金额:$121.49万
-
财政年份:2021
-
负责人:Roger L Shapiro
-
依托单位:
Tsepamo Plus: Expanded Congenital Abnormalities Surveillance with an Emulated Clinical Trial to Evaluate Weight Impact on Birth Outcomes for Newer ART Regimens
-
批准号:10495244
-
项目类别:
-
资助金额:$55.73万
-
财政年份:2021
-
负责人:Roger L Shapiro
-
依托单位:
Point-of-Care HIV Testing and Early Dolutegravir Use for Infants
-
批准号:10495250
-
项目类别:
-
资助金额:$27.07万
-
财政年份:2021
-
负责人:Roger L Shapiro
-
依托单位:
Closing Research Gaps in Antiretroviral Treatment for Pregnant Women and Infants Living with HIV
-
批准号:10696257
-
项目类别:
-
资助金额:$120.26万
-
财政年份:2021
-
负责人:Roger L Shapiro
-
依托单位:
Administrative Core
-
批准号:10495241
-
项目类别:
-
资助金额:$19.33万
-
财政年份:2021
-
负责人:Roger L Shapiro
-
依托单位:
Point-of-Care HIV Testing and Early Dolutegravir Use for Infants
-
批准号:10696262
-
项目类别:
-
资助金额:$21.76万
-
财政年份:2021
-
负责人:Roger L Shapiro
-
依托单位:
Administrative Core
-
批准号:10696258
-
项目类别:
-
资助金额:$17.38万
-
财政年份:2021
-
负责人:Roger L Shapiro
-
依托单位:
Tsepamo Plus: Expanded Congenital Abnormalities Surveillance with an Emulated Clinical Trial to Evaluate Weight Impact on Birth Outcomes for Newer ART Regimens
-
批准号:10696260
-
项目类别:
-
资助金额:$61.88万
-
财政年份:2021
-
负责人:Roger L Shapiro
-
依托单位:
Closing Research Gaps in Antiretroviral Treatment for Pregnant Women and Infants Living with HIV
-
批准号:10381142
-
项目类别:
-
资助金额:$134.08万
-
财政年份:2021
-
负责人:Roger L Shapiro
-
依托单位:
Administrative Core
-
批准号:10381143
-
项目类别:
-
资助金额:$22.35万
-
财政年份:2021
-
负责人:Roger L Shapiro
-
依托单位:
Point-of-Care HIV Testing and Early Dolutegravir Use for Infants
-
批准号:10381147
-
项目类别:
-
资助金额:$22.35万
-
财政年份:2021
-
负责人:Roger L Shapiro
-
依托单位:
Expansion of research and mentoring to improve birth outcomes and treatment outcomes among HIV-affected children in Botswana
-
批准号:10329944
-
项目类别:
-
资助金额:$17.64万
-
财政年份:2018
-
负责人:Roger L Shapiro
-
依托单位:
Botswana Birth Outcomes Surveillance Extension
-
批准号:10198964
-
项目类别:
-
资助金额:$58.48万
-
财政年份:2018
-
负责人:Roger L Shapiro
-
依托单位:
Botswana Birth Outcomes Surveillance Extension
-
批准号:10434695
-
项目类别:
-
资助金额:$57.78万
-
财政年份:2018
-
负责人:Roger L Shapiro
-
依托单位:
Botswana Birth Outcomes Surveillance Extension
-
批准号:10001130
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2018
-
负责人:Roger L Shapiro
-
依托单位:
Botswana Birth Outcomes Surveillance Extension
-
批准号:9754230
-
项目类别:
-
资助金额:$62.38万
-
财政年份:2018
-
负责人:Roger L Shapiro
-
依托单位:
Expansion of research and mentoring opportunities to reduce the burden of maternal and pediatric HIV in Botswana
-
批准号:10762238
-
项目类别:
-
资助金额:$18.78万
-
财政年份:2018
-
负责人:Roger L Shapiro
-
依托单位:
Birth Outcomes Surveillance in Botswana
-
批准号:9268787
-
项目类别:
-
资助金额:$51.81万
-
财政年份:2014
-
负责人:Roger L Shapiro
-
依托单位:
Birth Outcomes Surveillance in Botswana
-
批准号:9052770
-
项目类别:
-
资助金额:$51.42万
-
财政年份:2014
-
负责人:Roger L Shapiro
-
依托单位:
Birth Outcomes Surveillance in Botswana
-
批准号:8729127
-
项目类别:
-
资助金额:$51.06万
-
财政年份:2014
-
负责人:Roger L Shapiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
快速凝固ATI 718Plus镍基高温合金γ′/γ′′相复合结构组织调控
-
批准号:52374396
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:郭倩颖
-
依托单位:
基因组原位BE-PLUS-AID调控G-四链体新方法的建立及应用研究
-
批准号:CSTB2023NSCQ-MSX0456
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:江雯
-
依托单位:
线上强化失眠认知行为治疗(Smart-CBTI plus)对失眠障碍合并焦虑、抑郁患者的随机对照研究
-
批准号:20Y11906600
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:苑成梅
-
依托单位:
一种基于调控元件的新型碱基编辑工具BE-PLUS-AID的建立及其应用
-
批准号:31901049
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:江雯
-
依托单位:
Max-plus代数上的super本征问题
-
批准号:11901486
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:王绘莉
-
依托单位:
Jacobi形式的Kohnen plus空间及其应用
-
批准号:11901411
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2019
-
负责人:苏仁和
-
依托单位:
CST蛋白复合体组分基因突变导致"遗传性端粒综合症"Coats Plus症的致病机理研究
-
批准号:81971305
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:冯旭阳
-
依托单位:
基于影像分区集成CNN技术的早产儿视网膜plus病变精准识别
-
批准号:LSY19H180011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2018
-
负责人:郑晓雨
-
依托单位:
CSP I-plus 修饰的内皮抑制素靶向抑制肝细胞癌转移的研究
-
批准号:81502520
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2015
-
负责人:马艳
-
依托单位:
脱硝催化剂对零价汞的催化氧化机制及多效SCR-Plus协同催化体系的构建
-
批准号:21277088
-
项目类别:面上项目
-
资助金额:85.0万元
-
批准年份:2012
-
负责人:晏乃强
-
依托单位: